1. Home
  2. Solutions
  3. Medical Imaging
  4. Imaging therapeutic expertise
  5. Oncology

Oncology

Experts in the complex world of clinical trial oncology response criteria implementation

As the pipeline of potential cancer treatments expands, the number of clinical trials utilising imaging will continue to increase. Whether a trial is assessing longest diameter, sum of the products of diameters (SPD), tumour volume or other endpoints, we’re equipped to analyse data and deliver structural and volumetric measurements for a variety of oncology/haematology assessment criteria and imaging modalities. Experienced scientific and medical teams will also work closely with you to tailor your plan by implementing modifications to your published criteria. Additionally, we can provide specialised assessments of other structural or functional parameters through custom algorithms – offering robust and reliable solutions.

Oncology Imaging experience in the last five years:

  • 555

    Clinical trials

  • 130,382

    Patients

  • 16,840

    Sites

Oncology clinical trials face new challenges with the continued advent of novel therapeutic areas in targeted cancer therapies and personalised immunotherapy. This increases the pressure to deliver precise tumor phenotyping, staging and early outcome predictors in trials. These are key areas where medical imaging is proving to be a critical component for the timely delivery of endpoints in oncology trials.

ICON has a highly experienced Oncology imaging service that is underpinned by a robust team of specialists that have more than 550 Oncology imaging trials under their wing, contributing to over 21 approvals by the FDA.

We work with thousands of sites across the globe to provide support, image quality assessments, reconciliation, and post processing.

Our team of highly trained specialists include key opinion leaders in radiology and clinical oncology, medical imaging experts, oncology study coordinators, biomedical engineers, statisticians, and allied support personnel.

Our specialists have vast experience with a wide variety of cancers, their treatments, and their image assessment criteria. They have mastered imaging technologies including CT, MRI, PET-CT, Nuclear Medicine, and Ultrasound which ensures your requirements are met for the successful completion of your trial.

  • Indications include: Breast, Colorectal, Gastric, Glioblastoma, Glioma, Head and Neck, Lung, Lymphoma, Melanoma, Ovarian Prostate, Renal Cell
  • Criteria include:RECIST, mRECIST, Choi, RANO, Cheson, Lugano Classification, Halleck, iRECIST, RECIL, iRANO/bmRANO/pedRANO, PCWG, PCWG3

Delivering benefits to your oncology study:

Global radiology expertise

Access to over 700 highly trained radiologists with experience in body imaging, PET imaging, and nuclear medicine.

Integrated clinical and medical imaging teams

Direct communication between clinical and imaging service teams supports efficient project management, streamlined study start-up, and coordinated delivery throughout the trial.

Focus on critical study timelines

Our teams prioritise key milestones from study start-up to first patient in (FPI), and from last patient out (LPO) to database lock.

Specialist support across the study lifecycle

In-house scientific experts, data management specialists, medical writing, and translation services provide comprehensive support for oncology imaging studies.

High-quality training for study teams

Imaging-specific training for CTM and CRA teams supports timely image submissions, effective site communication, and stronger overall study alignment.

Proactive collaboration and risk management

Cross-functional accountability enables early risk identification, lower query rates, and timely implementation of corrective and preventative actions.

Find out more:

Discover how ICON Medical Imaging can enhance your clinical trials

Contact us
In this section

Connect with us